N/A
N=288
Lay Health Worker Led Symptom Assessment Intervention
Cancer
Bottom Line
View on ClinicalTrials.gov: NCT03737058 ↗Enrolled (actual)
288
Serious AEs
0.0%
Results posted
Feb 2025
Primary outcome: Primary: Edmonton Symptom Assessment Scale Score (ESAS) — 9.6; 7.2 score on a scale
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- Program participants (Behavioral)
- Age
- Pediatric, Adult, Older Adult
- Sex
- All
- Sponsor
- Stanford University
- Primary completion
- Dec 2021
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Edmonton Symptom Assessment Scale Score (ESAS) |
9.6; 7.2 | — |
| SECONDARY Incidence of Emergency Department Visits |
0.92; 0.61 | — |
| SECONDARY Hospitalization Visits (Claims Review) |
1.02; 0.72; 0.10; 0.18 | — |
| SECONDARY Intensive Care Unit Visits (Claims Review) |
0.66; 0.60 | — |
| SECONDARY Total Health Care Costs (Claims Review) |
31,946; 21,266 | — |
| SECONDARY Change in Patient Satisfaction With Care Using the Consumer Assessment of Health Care Providers and Systems -General Survey |
8.34; 8.10; 8.10; 9.25; -0.23; 1.15 | — |
Summary
Rising costs and poor patient experiences from under-treated symptoms have led to the demand for approaches that improve patients' experiences and lower expenditures. This observational project assigned a lay health worker to conduct proactive symptom assessments intended to achieve these goals among patients with advanced cancer.
Eligibility Criteria
Inclusion Criteria
- Clinical diagnosis of stage 3 and 4 cancer
- Clinical diagnosis of hematologic malignancy
- Must receive care at the Oncology Institute of Hope and Innovation
- Must be an enrollee of CareMore Medicare Advantage
Exclusion Criteria
None
Data sourced from ClinicalTrials.gov (NCT03737058). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.